Cover Image
Market Research Report

Polyphor Ltd - Product Pipeline Review - 2016

Published by Global Markets Direct Product code 253788
Published Content info 39 Pages
Delivery time: 1-2 business days
Price
Back to Top
Polyphor Ltd - Product Pipeline Review - 2016
Published: December 21, 2016 Content info: 39 Pages
Description

Summary

Global Markets Direct's,'Polyphor Ltd - Product Pipeline Review - 2016', provides an overview of the Polyphor Ltd's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Polyphor Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Polyphor Ltd
  • The report provides overview of Polyphor Ltd including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Polyphor Ltd's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Polyphor Ltd's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Polyphor Ltd's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Polyphor Ltd
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Polyphor Ltd's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
Product Code: GMDHC08172CDB

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Polyphor Ltd Snapshot
    • Polyphor Ltd Overview
    • Key Facts
  • Polyphor Ltd - Research and Development Overview
    • Key Therapeutic Areas
  • Polyphor Ltd - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Polyphor Ltd - Pipeline Products Glance
    • Polyphor Ltd - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Polyphor Ltd - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Polyphor Ltd - Drug Profiles
    • balixafortide - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • POL-5551 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • POL-6014 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • POL-6926 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • POL-7001 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • POL-7080 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • POL-7080 Follow-On - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Small Molecules for Unspecified Indication - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Synthetic Peptides for Unspecified Indication - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Synthetic Peptides to Agonize FPR1/2 for Immunology and Infectious Disease - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Synthetic Peptides to Antagonize FPR1/2 for Immunology and Infectious Disease - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Polyphor Ltd - Pipeline Analysis
  • Polyphor Ltd - Pipeline Products by Target
  • Polyphor Ltd - Pipeline Products by Route of Administration
  • Polyphor Ltd - Pipeline Products by Molecule Type
  • Polyphor Ltd - Pipeline Products by Mechanism of Action
  • Polyphor Ltd - Dormant Projects
  • Polyphor Ltd - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • POL-7080
  • Polyphor Ltd - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Polyphor Ltd, Key Facts
  • Polyphor Ltd - Pipeline by Indication, 2016
  • Polyphor Ltd - Pipeline by Stage of Development, 2016
  • Polyphor Ltd - Monotherapy Products in Pipeline, 2016
  • Polyphor Ltd - Partnered Products in Pipeline, 2016
  • Polyphor Ltd - Partnered Products/ Combination Treatment Modalities, 2016
  • Polyphor Ltd - Phase II, 2016
  • Polyphor Ltd - Phase I, 2016
  • Polyphor Ltd - Preclinical, 2016
  • Polyphor Ltd - Discovery, 2016
  • Polyphor Ltd - Pipeline by Target, 2016
  • Polyphor Ltd - Pipeline by Route of Administration, 2016
  • Polyphor Ltd - Pipeline by Molecule Type, 2016
  • Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016
  • Polyphor Ltd - Dormant Developmental Projects,2016
  • Polyphor Ltd - Discontinued Pipeline Products, 2016

List of Figures

  • Polyphor Ltd - Pipeline by Top 10 Indication, 2016
  • Polyphor Ltd - Pipeline by Stage of Development, 2016
  • Polyphor Ltd - Monotherapy Products in Pipeline, 2016
  • Polyphor Ltd - Pipeline by Target, 2016
  • Polyphor Ltd - Pipeline by Route of Administration, 2016
  • Polyphor Ltd - Pipeline by Molecule Type, 2016
  • Polyphor Ltd - Pipeline Products by Mechanism of Action, 2016
Back to Top